...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
AGORACOM NEWS FLASH

Dear Agoracom Family,

I want to thank all of you for your patience with us over the past 48 hours and apologize for what was admittedly a botched launch of our new site.

As you can see, we have reverted back to the previous version of the site while we address multiple forum functionality flaws that inexplicably made their way into the launch.

To this end:

1.We have identified 8 fundamental but easily fixable flaws that will be corrected in the coming week, so that you can continue to use the forums exactly as you've been accustomed to.

2.Additionally we will also be implementing a couple of design improvements to "tighten up" the look and feel of the forums.

Have a great Sunday, especially those of you like me that are celebrating Orthodox Easter ... As well as those of you who are also like me and mourning another Maple Leafs Game 7 exit ... Ugggh!

Sincerely,

George et al

Message: Volume almost 100,000 at 11am

Apologized many times?  What do you mean?  I thought he did a bloody good job in explaining the upside (maybe not as much on the science side; probably coz he would have lost his readers).  But I guess, like all analysts, no matter how bullish they are, they need to sound credible...so putting a $50 target price would have streched the Makalu credibility beyond acceptable limits.

For a contrast, look at the Roth analyst report.  Read between the lines...and he says $20 if the Phase 3 trial goes as expected.  But then he puts zero value on CKD, Dementia etc.  I bet you, the Roth fellow will bump up his price to $30 and start pricing in the CKD etc.  Usual analyst games...keep the upside in your pocket if you are bullish!

Share
New Message
Please login to post a reply